Horizon Funds - Horizon Flexible Income ETF
US ˙ BATS ˙ US33938J1060

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Rebecca B Robertson. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Rebecca B Robertson har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Director 9.215
US:TNDM / Tandem Diabetes Care, Inc. Director 13.783
US:FLXN / Horizon Funds - Horizon Flexible Income ETF 10% Owner 20.739
US:GKOS / Glaukos Corporation 496
US:PZRX / PhaseRx, Inc. 10% Owner 1.931.094
US:INGN / Inogen, Inc. 10% Owner 55.345
US:EYES / Vivani Medical Inc 10% Owner 4.370.964
US:PODD / Insulet Corporation 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Rebecca B Robertson. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb FLXN / Horizon Funds - Horizon Flexible Income ETF – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2016-06-08 FLXN Versant Ventures III, LLC 710.091 14,0000 710.091 14,0000 9.941.274 292 29.2600 10.835.989 109,00
2016-06-08 FLXN Versant Ventures III, LLC 4.194 14,0000 4.194 14,0000 58.716

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insidersalg FLXN / Horizon Funds - Horizon Flexible Income ETF – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insiderkøb GKOS / Glaukos Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GKOS / Glaukos Corporation Insider Trades
Insidersalg GKOS / Glaukos Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GKOS / Glaukos Corporation Insider Trades
Insiderkøb INGN / Inogen, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INGN / Inogen, Inc. Insider Trades
Insidersalg INGN / Inogen, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2015-01-05 INGN Versant Ventures II LLC 7.946 30,9790 7.946 30,9790 246.159 35 29.7800 -9.527 -3,87
2014-12-23 INGN Versant Ventures II LLC 9.785 29,7403 9.785 29,7403 291.009
2014-11-19 INGN Versant Ventures II LLC 3.500 24,2162 3.500 24,2162 84.757
2014-11-18 INGN Versant Ventures II LLC 3.895 24,9177 3.895 24,9177 97.054
2014-11-18 INGN Versant Ventures II LLC 7.953 24,7904 7.953 24,7904 197.158
2014-11-17 INGN Versant Ventures II LLC 7.534 24,8636 7.534 24,8636 187.322
2014-11-17 INGN Versant Ventures II LLC 5.343 24,8852 5.343 24,8852 132.962
2014-11-14 INGN Versant Ventures II LLC 3.928 25,0627 3.928 25,0627 98.446
2014-11-13 INGN Versant Ventures II LLC 5.505 25,1844 5.505 25,1844 138.640
2014-11-13 INGN Versant Ventures II LLC 5.505 25,1814 5.505 25,1814 138.624
2014-11-10 INGN Versant Ventures II LLC 3.041 24,5682 3.041 24,5682 74.712
2014-11-10 INGN Versant Ventures II LLC 5.596 24,4781 5.596 24,4781 136.979
2014-11-10 INGN Versant Ventures II LLC 2.992 24,4201 2.992 24,4201 73.065
2014-11-07 INGN Versant Ventures II LLC 3.150 23,9499 3.150 23,9499 75.442
2014-11-06 INGN Versant Ventures II LLC 4.238 24,5617 4.238 24,5617 104.092
2014-10-24 INGN Versant Ventures II LLC 4.647 20,7565 4.647 20,7565 96.455

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INGN / Inogen, Inc. Insider Trades
Insiderkøb VANI / Vivani Medical, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VANI / Vivani Medical, Inc. Insider Trades
Insidersalg VANI / Vivani Medical, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VANI / Vivani Medical, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Rebecca B Robertson som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-05 2025-09-03 4 CBLL Ceribell, Inc.
Common Stock
S - Sale X -827 9.215 -8,24 11,36 -9.395 104.682
2025-06-20 2025-06-18 4 CBLL Ceribell, Inc.
Common Stock
S - Sale X -11.188 10.042 -52,70 17,85 -199.706 179.250
2025-06-20 2025-06-17 4 CBLL Ceribell, Inc.
Common Stock
S - Sale X -7.445 21.230 -25,96 17,63 -131.255 374.285
2025-06-17 2025-06-16 4 CBLL Ceribell, Inc.
Common Stock
S - Sale X -20.000 28.675 -41,09 17,14 -342.800 491.490
2025-06-17 2025-06-16 4 CBLL Ceribell, Inc.
Common Stock
M - Exercise X 19.455 48.675 66,58 3,65 71.011 177.664
2025-06-17 2025-06-16 4 CBLL Ceribell, Inc.
Common Stock
M - Exercise X 545 29.220 1,90 2,24 1.221 65.453
2025-06-17 2025-06-10 4 CBLL Ceribell, Inc.
Common Stock
A - Award 8.828 28.675 44,48
2025-05-23 2025-05-22 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 4.387 13.783 46,69 20,64 90.548 284.481
2024-10-16 2024-10-11 4 CBLL Ceribell, Inc.
Common Stock
A - Award 6.618 19.847 50,03
2024-10-10 3 CBLL Ceribell, Inc.
Common Stock
13.229
2024-05-24 2024-05-24 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 4.434 9.396 89,36 51,73 229.371 486.055
2023-05-26 2023-05-25 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 2.757 4.962 125,03
2022-05-19 2022-05-18 4 TNDM TANDEM DIABETES CARE INC
Restricted Stock Unit
M - Exercise 2.205 0 -100,00
2022-05-19 2022-05-18 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 2.205 2.205
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise 1.500 31.892 4,94 34,00 51.000 1.084.328
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -967 0 -100,00 97,10 -93.896
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -533 967 -35,53 96,05 -51.195 92.880
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.500 1.500 34,00 51.000 51.000
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise 1.500 31.892 4,94 34,00 51.000 1.084.328
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -967 0 -100,00 97,10 -93.896
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -533 967 -35,53 96,05 -51.195 92.880
2022-05-04 2022-05-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.500 1.500 34,00 51.000 51.000
2022-02-03 2022-02-01 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise 1.500 33.392 4,70 34,00 51.000 1.135.328
2022-02-03 2022-02-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -533 0 -100,00 118,82 -63.331
2022-02-03 2022-02-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -667 533 -55,58 117,89 -78.633 62.835
2022-02-03 2022-02-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -300 1.200 -20,00 116,63 -34.989 139.956
2022-02-03 2022-02-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.500 1.500 34,00 51.000 51.000
2021-11-03 2021-11-01 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise 1.108 34.892 3,28 34,00 37.672 1.186.328
2021-11-03 2021-11-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -278 0 -100,00 136,35 -37.905
2021-11-03 2021-11-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -1.222 278 -81,47 135,64 -165.752 37.708
2021-11-03 2021-11-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.108 1.500 282,65 34,00 37.672 51.000
2021-08-03 2021-08-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -1.500 392 -79,28 107,51 -161.264 42.144
2021-06-10 2021-06-09 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise -500 36.000 -1,37 34,00 -17.000 1.224.000
2021-06-10 2021-06-09 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -500 1.892 -20,90 90,00 -45.000 170.280
2021-06-10 2021-06-09 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 500 2.392 26,43 34,00 17.000 81.328
2021-06-03 2021-06-01 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise -1.000 36.500 -2,67
2021-06-03 2021-06-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -1.000 1.892 -34,58 85,11 -85.114 161.037
2021-06-03 2021-06-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.000 2.892 52,85 34,00 34.000 98.328
2021-06-01 2021-05-27 4 TNDM TANDEM DIABETES CARE INC
Restricted Stock Unit
M - Exercise -1.892 0 -100,00
2021-06-01 2021-05-27 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.892 1.892
2021-05-20 2021-05-18 4 TNDM TANDEM DIABETES CARE INC
Restricted Stock Unit
A - Award 2.205 2.205
2021-03-03 2021-03-01 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise -1.500 37.500 -3,85
2021-03-03 2021-03-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -1.500 0 -100,00 96,14 -144.214
2021-03-03 2021-03-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.500 1.500 34,00 51.000 51.000
2020-12-03 2020-12-01 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise -1.500 39.000 -3,70
2020-12-03 2020-12-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -1.500 0 -100,00 94,03 -141.040
2020-12-03 2020-12-01 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 1.500 1.500 34,00 51.000 51.000
2020-09-04 2020-09-02 4 TNDM TANDEM DIABETES CARE INC
Stock Option
M - Exercise -9.500 40.500 -19,00
2020-09-04 2020-09-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -500 0 -100,00 116,89 -58.445
2020-09-04 2020-09-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -866 500 -63,40 115,38 -99.921 57.691
2020-09-04 2020-09-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -4.466 1.366 -76,58 114,58 -511.693 156.510
2020-09-04 2020-09-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -1.800 5.832 -23,58 113,61 -204.503 662.589
2020-09-04 2020-09-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
S - Sale X -1.868 7.632 -19,66 112,31 -209.794 857.145
2020-09-04 2020-09-02 4 TNDM TANDEM DIABETES CARE INC
Common Stock
M - Exercise 9.500 9.500 34,00 323.000 323.000
2020-05-29 2020-05-27 4 TNDM TANDEM DIABETES CARE INC
Restricted Stock Unit
A - Award 1.892 1.892
2019-06-20 2019-06-18 4 TNDM TANDEM DIABETES CARE INC
Stock Option
A - Award 1.555 1.555
2019-01-09 3/A TNDM TANDEM DIABETES CARE INC
Common Stock
0
2019-01-08 2019-01-02 4 TNDM TANDEM DIABETES CARE INC
Stock Option
A - Award 50.000 50.000
2019-01-08 3 TNDM TANDEM DIABETES CARE INC
Common Stock
0
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 4.194 20.739 25,35 14,00 58.716 290.346
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 710.091 3.511.670 25,35 14,00 9.941.274 49.163.380
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 496 496
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 2.317 2.317
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 397 397
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 397 397
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 989 989
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 989 989
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 741 741
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 128.758 128.758
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
S - Sale -23.088 109.395 -17,43 23,98 -553.650 2.623.292
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
S - Sale -10.970 51.247 -17,63 23,98 -263.061 1.228.903
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other -9.892 46.804 -17,45
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other -505.297 2.379.539 -17,52
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 596.477 1.931.094 44,69 5,00 2.982.385 9.655.470
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -182.914 1.334.617 -12,05 0,01 -1.829 13.346
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -73.615 1.517.531 -4,63 0,01 -736 15.175
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 3.523 11.408 44,68 5,00 17.615 57.040
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -1.080 7.885 -12,05 0,01 -11 79
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -435 8.965 -4,63 0,01 -4 90
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -552 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -1.296 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -577 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -27.612 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -5.465 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -12.840 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -5.715 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -273.337 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -3.271 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -7.684 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -3.420 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -163.592 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -10.791 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -25.226 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -11.805 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -548.464 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -9.386 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -21.900 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -10.428 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -479.714 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -16.666 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -38.888 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -18.518 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -851.852 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -10.800 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -25.200 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -12.000 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -552.000 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -235 56.696 -0,41 18,00 -4.230 1.020.528
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 552 56.931 0,98
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 56.379 56.379
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -551 132.483 -0,41 18,00 -9.918 2.384.694
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 1.296 133.034 0,98
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 131.738 131.738
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -246 62.217 -0,39 18,00 -4.428 1.119.906
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 577 62.463 0,93
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 61.886 61.886
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -11.736 2.884.835 -0,41 18,00 -211.248 51.927.030
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 27.612 2.896.571 0,96
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 2.868.959 2.868.959
2015-05-11 2014-11-07 4/A INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2015-05-11 2014-11-06 4/A INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 1.469 3.782 63,51
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.199 13.640 61,59
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.596 5.596
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 2.798 3.041 1.151,44
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 243 243
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -42.216 0 -100,00
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 42.216 42.216
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -389.136 2.917.544 -11,77
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 4.682 4.682
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.539 52.985 49,48
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 8.916 13.196 208,32
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.834 17.834
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other -136.039 0 -100,00
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 13.682 3,68
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 136.039 136.039
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -778.272 1.263.716 -38,11
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -6.952 7.812 -47,09
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 4.459 16.329 37,57
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 56.385 46,25
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 87.719 25,52
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 87.461 25,61
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 85.497 26,35
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other -136.039 0 -100,00
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 972 17.301 5,95
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 56.871 0,86
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 88.205 0,55
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 389 56.516 0,69
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 778 54.941 1,44
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 136.039 136.039
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -778.272 1.263.716 -38,11
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -6.952 7.812 -47,09
2015-01-06 2015-01-05 4 INGN Inogen Inc
Common Stock
S - Sale -7.946 0 -100,00 30,98 -246.159
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 2.084 9.785 27,06
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.636 35.446 27,46
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 4.280 7,67
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 3.975 3.975
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.946 7.946
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 607 11.870 5,39
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.986 11.263 21,41
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 244 38.295 0,64
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.942 38.051 26,38
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 488 36.331 1,36
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.950 35.843 28,50
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-29 2014-12-23 4 INGN Inogen Inc
Common Stock
S - Sale -9.785 0 -100,00 29,74 -291.009
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 607 11.870 5,39
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.986 11.263 21,41
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 244 38.295 0,64
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.942 38.051 26,38
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 488 36.331 1,36
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.950 35.843 28,50
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 2.084 9.785 27,06
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.636 35.446 27,46
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 4.280 7,67
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 3.975 3.975
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.946 7.946
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.370.964
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
82.949
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
39.062
2014-11-19 2014-11-19 4 INGN Inogen Inc
Common Stock
S - Sale -3.500 0 -100,00 24,22 -84.757
2014-11-19 2014-11-18 4 INGN Inogen Inc
Common Stock
S - Sale -7.953 0 -100,00 24,79 -197.158
2014-11-19 2014-11-18 4 INGN Inogen Inc
Common Stock
S - Sale -3.895 3.500 -52,67 24,92 -97.054 87.212
2014-11-19 2014-11-17 4 INGN Inogen Inc
Common Stock
S - Sale -7.534 7.395 -50,47 24,86 -187.322 183.866
2014-11-19 2014-11-17 4 INGN Inogen Inc
Common Stock
S - Sale -5.343 40.569 -11,64 24,89 -132.962 1.009.568
2014-11-19 2014-11-17 4 INGN Inogen Inc
Common Stock
S - Sale -5.343 40.569 -11,64 24,89 -132.962 1.009.568
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-14 2014-11-14 4 INGN Inogen Inc
Common Stock
S - Sale -3.928 45.912 -7,88 25,06 -98.446 1.150.679
2014-11-14 2014-11-13 4 INGN Inogen Inc
Common Stock
S - Sale -5.505 49.840 -9,95 25,18 -138.640 1.255.190
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 3.919 7.701 103,62
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.170 27.810 103,89
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 14.929
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 7.953 6,51
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 7.467 7.467
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -113.112 0 -100,00
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 113.112 113.112
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -6.952 19.109 -26,68
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -778.272 2.528.408 -23,54
2014-11-14 2014-11-14 4 INGN Inogen Inc
Common Stock
S - Sale -3.928 45.912 -7,88 25,06 -98.446 1.150.679
2014-11-14 2014-11-13 4 INGN Inogen Inc
Common Stock
S - Sale -5.505 49.840 -9,95 25,18 -138.624 1.255.041
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 972 9.277 11,70
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 3.733 8.305 81,65
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 30.304 1,63
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 30.304 1,63
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 388 30.109 1,31
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.932 29.721 100,97
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 776 27.893 2,86
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -113.112 0 -100,00
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 113.112 113.112
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -778.272 2.528.408 -23,54
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -6.952 19.109 -26,68
2014-11-12 2014-11-10 4 INGN Inogen Inc
Common Stock
S - Sale -5.596 0 -100,00 24,48 -136.979
2014-11-12 2014-11-10 4 INGN Inogen Inc
Common Stock
S - Sale -3.041 0 -100,00 24,57 -74.712
2014-11-12 2014-11-10 4 INGN Inogen Inc
Common Stock
S - Sale -2.992 12.188 -19,71 24,42 -73.065 297.632
2014-11-07 2014-11-07 4 INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2014-11-07 2014-11-06 4 INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 1.469 3.782 63,51
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.199 13.640 61,59
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.596 5.596
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 2.798 3.041 1.151,44
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2014-11-07 2014-11-07 4 INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2014-11-07 2014-11-06 4 INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 1.398 4.572 44,05
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 486 3.174 18,08
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.595 14.889 60,20
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 9.294 2,68
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.595 3.321.569 0,17
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 3.315.974 0,01
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.596 15.180 58,39
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 388 9.584 4,22
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.594 14.789 60,84
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 194 9.195 2,16
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2014-10-28 2014-10-24 4 INGN Inogen Inc
Common Stock
S - Sale -4.647 0 -100,00 20,76 -96.455
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 2.313 2.313
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.441 8.441
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 4.404 4.647 1.812,35
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other -66.857 0 -100,00
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Stock Option (right to buy)
X - Other -2.250 6.750 -25,00
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Common Stock
X - Other 2.250 2.250 17,61 39.622 39.622
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -11.538 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -5.495 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -252.748 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series E Preferred Stock
C - Conversion -4.945 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -58.085 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -27.660 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -1.272.337 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series D Preferred Stock
C - Conversion -24.894 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -80.000 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -38.095 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -1.752.381 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series C Preferred Stock
C - Conversion -34.286 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -85.135 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -40.541 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -1.864.865 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Series B Preferred Stock
C - Conversion -36.486 0 -100,00
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 89.372 89.372
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 42.557 42.557
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 1.957.713 1.957.713
2007-05-17 2007-05-14 4 PODD INSULET CORP
Common Stock
C - Conversion 38.301 38.301
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)